Skip to main content
SpringerLink
Log in

Meta-analysis confirms mortality risk of higher Hb targets for erythropoietins

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Phrommintikul A, Haas SJ, Elsik M, Krum H.Mortality and taget haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 369: 381-388, No. 9559, 3 Feb 2007

  2. Strippoli GFM, Tognoni G, Navaneethan SD, Nicolucci A, Craig JC.Haemoglobin targets: we were wrong, time to move on. Lancet 369: 346-350, No. 9559, 3 Feb 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meta-analysis confirms mortality risk of higher Hb targets for erythropoietins. React. Wkly. 1138, 1 (2007). https://doi.org/10.2165/00128415-200711380-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711380-00001

Keywords

Search

Navigation